logo
Select company
Select metric
-6782.19%EBIT Margin
VS
Market
2
Sector
8
Industry
13
History
9
$ 0.56Close
$ 0.43 - $ 1.98 52-Week Range
Ticker Information

Ticker

SILO

Company Name

SILO PHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SILO PHARMA INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SILO - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -4.89M-6782.19%$ 72.1K
3/31/2025$ -4.62M-6403.94%$ 72.1K
12/31/2024$ -4.39M-6085.54%$ 72.1K
9/30/2024$ -3.78M-5240.29%$ 72.1K
6/30/2024$ -3.51M-4867.69%$ 72.1K
3/31/2024$ -3.59M-4980.26%$ 72.1K
12/31/2023$ -3.7M-5125.81%$ 72.1K
9/30/2023$ -4.23M-5871.92%$ 72.1K
6/30/2023$ -4.56M-6322.87%$ 72.1K
3/31/2023$ -4.21M-5834.24%$ 72.1K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SILO PHARMA INC's latest trailing twelve months (TTM) EBIT % stands at -3890.07%.
  • Over the past 5 years, SILO PHARMA INC's average EBIT % has been -3335.54%.
  • The median EBIT % for SILO PHARMA INC during this period was -5053.04%
  • SILO PHARMA INC reached its highest EBIT % over the past 5 years at 5629.09%.
  • The lowest EBIT % recorded by SILO PHARMA INC in the same timeframe -6782.19%

SILO PHARMA INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
AIM : AIM IMMUNOTECH INC -12858.68%CDIO : CARDIO DIAGNOSTICS HOLDINGS INC -31956.48%IBO : IMPACT BIOMEDICAL INC -533357.14%TTNP : TITAN PHARMACEUTICALS INC -PALI : PALISADE BIO INC -ENSC : ENSYSCE BIOSCIENCES INC -ADTX : ADITXT INC -250836.49%PMCB : PHARMACYTE BIOTECH INC -THAR : THARIMMUNE INC -APVO : APTEVO THERAPEUTICS INC -

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for SILO PHARMA INC is calculated as follows: EBIT [ $ -2.3M ] / Revenues [ $ 59.1K ]
(=) EBIT % [ -3890.07% ]

SILO - EBIT Margin, Last 5 years

-6782.19%

Minimum

Jun 30, 2025

5629.09%

Maximum

Jun 30, 2022

-3335.54%

Average

-5053.04%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%